HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dandruff monograph

This article was originally published in The Rose Sheet

Executive Summary

FDA amends December 1992 OTC dandruff, seborrheic dermatitis, and psoriasis drug products final monograph in the Jan. 28 Federal Register to include products containing .6% micronized selenium sulfide for the control of dandruff, effective Jan. 28, 1995. The agency proposed the amendment in April 1993 ("The Rose Sheet" April 5, p. 1). The amendment responded to a 1991 petition from Selsun Blue manufacturer Ross Labs
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel